In the US medical devices industry, there were 13 private equity deals announced in Q1 2024, worth a total value of $3.7bn, according to GlobalData’s Deals Database. The $2.5bn management buy-out (mbo) Agiliti by Thomas H. Lee Partners was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes and the Private Equity deal activity are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, private equity deal activity in the US increased by 760% in Q1 2024 compared with the previous quarter’s total of $430.5m and rose by 1607% as compared to Q1 2023. Related deal volume increased by 8% in Q1 2024 versus the previous quarter and was 7% lower than in Q1 2023.
The top-ranked financial advisors supporting these private equity deals in the US in Q1 2024 were Harris Williams; Jefferies Financial Group; KeyCorp with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these private equity deals in the US in Q1 2024 were Wilson Sonsini Goodrich & Rosati Professional; DLA Piper International; Gibson Dunn with 2, 1, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q1 2024 – Thematic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.